Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 27, 2012 - Issue 5
Submit an article Journal homepage
656
Views
24
CrossRef citations to date
0
Altmetric
Research Article

QSARs on human carbonic anhydrase VA and VB inhibitors of some new not yet synthesized, substituted aromatic/heterocyclic sulphonamides as anti-obesity agent

Shalini SinghQSAR & Cheminformatics Laboratory, Department of Chemistry, Bareilly College, Bareilly, IndiaCorrespondence[email protected]
&
Claudiu T. SupuranUniversita degli Studi di Firenze, Polo Scientifico, Laboratorio di Chimica Bioinorganica, Sesto Fiorentino (Florence), Italy
Pages 666-672 | Received 03 Jul 2011, Accepted 17 Jul 2011, Published online: 08 Sep 2011

References

  • Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–181.
  • Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336–4350.
  • Supuran CT, Scozzafava A, Conway J, eds. Carbonic anhydrase-its inhibitors and activators; Boca Raton (FL): CRC Press USA; 2004. P1–376.
  • Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146–189.
  • Winum JY, Rami M, Scozzafava A, Montero JL, Supuran CT. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents. Med Res Rev 2008;28:445–463.
  • Lynch CJ, Fox H, Hazen SA, Stanley BA, Dodgson S, Lanoue KF. Role of hepatic carbonic anhydrase in de novo lipogenesis. Biochem j 1995;310 (Pt 1):197–202.
  • Hazen SA, Waheed A, Sly WS, LaNoue KF, Lynch CJ. Differentiation-dependent expression of CA V and the role of carbonic anhydrase isozymes in pyruvate carboxylation in adipocytes. Faseb J 1996;10:481–490.
  • Güzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB. Bioorg Med Chem 2009;17:4894–4899.
  • Hebebrand J, Antel J, Preuschoff U, David S, Sann H, Weske M. Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity. WO Patent, 07821, 2002.
  • BROOD (version 2.0.0), OpenEye Science Software, 3600 Cerrillos Road, Suite 1107, Santa Fe, USA, 2010.
  • OMEGA (version 2.4.3), OpenEye Science Software, 3600 Cerrillos Road, Suite 1107, Santa Fe, USA, 2010.
  • Tresadern G, Bemporad D, Howe T. A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor. J Mol Graph Model 2009;27:860–870.
  • Halgren TA. MMFF VI. MMFF94s option for energy minimization studies. J Comput Chem 1999;20:720–729
  • Stewart JJP. Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements. j Mol Model 2007;13:1173–1213.
  • Stewart JJP. MOPAC2009, Stewart Computational Chemistry,Colorado Springs, CO, USA, http://OpenMOPAC.net 2008.
  • PRECLAV V. 1011 (documentation included) is available from Center of Organic Chemistry-Bucharest, 2010.
  • Tarko L. Calculate QSPR/QSAR cu ajutorul programului PRECLAV. Rev Chim (Bucuresti) 2005; 56:639.
  • Tarko L, Lupescu I, Groposila-Constantinescu D. Sweetness power QSARs by PRECLAV software. Arkivoc 2005;x:255.
  • Tarko L, Stecoza CE, Ilie C, Chifiriuc MC. QSAR Studies on antibacterial activity of some substituted dihydrodibenzothiepins. Rev Chim (Bucuresti) 2009;60:476
  • Tarko L. QSAR studies regarding the inhibition of the carbonic anhydrase by the sulfonamides containing a picolinoyl group. Rev Chim (Bucuresti) 2007; 58:192.
  • Tarko L, Avram S, Mihailescu D. Prediction for antidepressants activity using QSAR Study. Rev Chim (Bucuresti), 2011; 62:371.
  • Done R, Mandrila G, Tarko L. QSAR study concerning toxicity and threshold limit value VL8 of chlorine containing compounds. Rev Chim (Bucuresti) 2009;60:214.
  • Singh Shalini Khadikar, PV, Scozzafava A, Supuran CT. QSAR studies for the inhibition of the trans membrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software. J Enzyme Inhib Med Chem 2009;24:337–349.
  • Singh S. Comparative QSAR studies on the novel series of thiazolones and tetrazole derivatives as HCV NS5B polymerase allosteric inhibitors. Lett Drug Des Discov 2009;6:286–297.
  • Singh Shalini, Singh Sarika, Shukla Poonam. Modeling of novel HIV-1 protease inhibitors incorporating N-Aryl-oxazolidinone-5-carboxamides as P2 ligands using quantum chemical and topological finger print descriptors. Med Chem Res 2010; DOI 10.1007/s00044-010–9416-0.
  • Tarko L. Fragmentarea virtual a moleculelor si evaluarea similaritatilor. Rev Chim (Bucuresti) 2004;55:539.
  • Tarko L. A procedure for virtual fragmentation of molecules into functional groups. ARKIVOC 2004;xiv:74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.